Andrian Titus, Siriteanu Lucian, Covic Andreea Simona, Ipate Cristina Alexandra, Miron Adelina, Morosanu Corneliu, Caruntu Irina-Draga, Covic Adrian
Nephrology Clinic, Dialysis and Renal Transplant Center, C. I. Parhon University Hospital, 700503 Iasi, Romania.
Department of Internal Medicine, 'Grigore T. Popa' University of Medicine, 700115 Iasi, Romania.
J Clin Med. 2023 Mar 18;12(6):2364. doi: 10.3390/jcm12062364.
Rates of late allograft loss have improved slowly in the last decades. Well described traditional risk factors that influence allograft survival include cardiovascular events, rejection, infections and post-transplant neoplasia. Here, we critically evaluate the influence of several non-immunological, non-traditional risk factors and describe their impact on allograft survival and cardiovascular health of kidney transplant recipients. We assessed the following risk factors: arterial stiffness, persistent arteriovenous access, mineral bone disease, immunosuppressive drugs residual levels variability, hypomagnesemia, glomerular pathological alterations not included in Banff criteria, persistent inflammation and metabolic acidosis.
在过去几十年中,移植肾晚期丢失率改善缓慢。影响移植肾存活的传统危险因素已得到充分描述,包括心血管事件、排斥反应、感染和移植后肿瘤形成。在此,我们严格评估了几种非免疫性、非传统危险因素的影响,并描述了它们对肾移植受者移植肾存活和心血管健康的影响。我们评估了以下危险因素:动脉僵硬度、持续性动静脉通路、矿物质骨病、免疫抑制药物残留水平变异性、低镁血症、未纳入班夫标准的肾小球病理改变、持续性炎症和代谢性酸中毒。